Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Safeguard Scientifics Inc is engaged in the development of early- and growth-stage businesses by providing capital and relevant expertise to fuel the growth of an attractive portfolio of technology-enabled healthcare, digital media and other companies. Safeguard generally promotes the growth and dev... Safeguard Scientifics Inc is engaged in the development of early- and growth-stage businesses by providing capital and relevant expertise to fuel the growth of an attractive portfolio of technology-enabled healthcare, digital media and other companies. Safeguard generally promotes the growth and development of these companies through the Board representation and minority equity ownership. In addition to supporting the companies, Safeguard's strategy focuses on pursuing monetization opportunities in order to return value to shareholders. Mehr anzeigen
Bright Lights Conference Will Showcase 50 of the Most Innovative U.S. Small Cap Companies with Disruptive Intellectual Property in San Francisco on May 10 - 12, 2010 SANTA MONICA, Calif., Feb. 17...
NORWOOD, Mass., Jan. 12 /PRNewswire/ -- Molecular Biometrics®, Inc., a metabolomics company developing novel clinical diagnostic tools for applications in personalized medicine, today announced...
New Molecular Tests and Increased Case Volume Continue to Drive Revenue Growth ALISO VIEJO, Calif., May 6 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier anatomic pathology and...
The Clarient Insight(R) Dx Breast Cancer Profile Assists Physicians In Identifying Recurrence Risk and the Need for Chemotherapy ALISO VIEJO, Calif., May 5 /PRNewswire-FirstCall/ -- Clarient...
FOXA1 biomarker predicts likelihood of recurrence and long-term disease-free survival of breast cancer patients; Further strengthens Company's breast cancer menu ALISO VIEJO, Calif., April 23...
Presentation Scheduled for 8:45am EDT ALISO VIEJO, Calif., March 12 /PRNewswire-FirstCall/ -- Clarient, Inc. (NASDAQ:CLRT), a premier technology and services resource for pathologists...
New Molecular Tests and Increasing Case Volumes Drive 78 Percent Revenue Growth in the Fourth Quarter of 2008 as Compared to the Prior Year Period ALISO VIEJO, Calif., March 11...
- Augments Senior Management Team with more than 30 Years Experience in Biopharmaceutical Manufacturing, Engineering, Technical Services and Validation - PRINCETON, N.J., Feb. 14 /PRNewswire/...
Amendment extends lease through 2016 with options through 2026 PRINCETON, N.J., April 25 /PRNewswire/ -- Laureate Pharma, Inc., a full- service biopharmaceutical development and protein...
Former Microsoft Executive to Assume Key Management Position NORWALK, Conn., April 10 /PRNewswire-FirstCall/ -- EDGAR(R) Online, Inc. (NASDAQ:EDGR) announced today that Philip Moyer will assume...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
